|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.72 CHF | +0.98% |
|
+10.67% | +22.97% |
| 02:17pm | Stifel Adjusts Price Target on Alcon to $100 From $95, Maintains Buy Rating | MT |
| 02:17pm | Oppenheimer Upgrades Alcon to Outperform From Perform, $103 Price Target | MT |
Novartis named Mike Ball as new division head at Alcon. Ball joins Novartis from Hospira, where he was CEO from 2011 until recently.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.97% | 43.61B | |
| +3.52% | 19.07B | |
| -17.14% | 2.36B | |
| +10.71% | 1.85B | |
| +27.62% | 1.23B | |
| -35.12% | 753M | |
| -41.32% | 691M | |
| -7.76% | 674M | |
| +23.43% | 497M | |
| +27.48% | 491M |
ALCON INC. 
